-+ 0.00%
-+ 0.00%
-+ 0.00%

FATE THERAPEUTICS - FT819 ALSO BEING EVALUATED IN SLE; PHASE 2 TRIAL PLANNED IN LUPUS NEPHRITIS

Reuters·07/06/2026 12:32:00

Please log in to view news